This company seems to have been delisted
Reason: Acquired by Novo Holdings
Last recorded trade on: February 19, 2025
Source: https://www.catalent.com/catalent-news/novo-holdings-completes-acquisition-of-catalent/
Reason: Acquired by Novo Holdings
Last recorded trade on: February 19, 2025
Source: https://www.catalent.com/catalent-news/novo-holdings-completes-acquisition-of-catalent/
Catalent
CTLT
HK$492.45
Share price
0.00%
Change (1 day)
12.63%
Change (1 year)
Categories
Catalent is an American pharmaceutical contract research and development company.
EPS for Catalent (CTLT)
EPS in 2023 (TTM): -HK$10.14
According to Catalent's latest financial reports the company's current EPS (TTM) is -HK$10.01. In 2022 the company made an earnings per share (EPS) of HK$17.61 a decrease over its 2021 EPS that were of HK$25.37.
EPS history for Catalent from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -HK$10.14 | -157.57% |
| 2022 | HK$17.61 | -30.58% |
| 2021 | HK$25.37 | 79.67% |
| 2020 | HK$14.12 | 114.12% |
| 2019 | HK$6.59 | -15% |
| 2018 | HK$7.76 | 75.44% |
| 2017 | HK$4.42 | -22.97% |
| 2016 | HK$5.74 | -59.56% |
| 2015 | HK$14.20 | 282.05% |
| 2014 | HK$3.72 | -378.2% |
| 2013 | -HK$1.34 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | HK$6.13 | -161.24% | 🇺🇸 USA |
 | -HK$5.82 | -41.86% | 🇺🇸 USA |
 | -HK$10.94 | 9.30% | 🇮🇪 Ireland |
 | HK$49.57 | -595.35% | 🇺🇸 USA |